Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Osiris Therapeutics Concludes Successful Defense of Stem Cell Patent Challenge in Australia
Latest Articles from Benzinga.com
Posted on February 18, 2013 at 19:45 PM EST
Osiris Therapeutics (NASDAQ: OSIR ) announced today the successful conclusion of a patent challenge in Australia by an opponent whose identity under Australian law was not disclosed. The patent at issue covers the
Read More >>
GBL INV HSE
NewStar Financial, Inc.
Osiris Therapeutics, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here